Drug Interactions between remdesivir and st. john's wort
This report displays the potential drug interactions for the following 2 drugs:
- remdesivir
- st. john's wort
Interactions between your drugs
St. John's wort remdesivir
Applies to: st. john's wort and remdesivir
MONITOR: Theoretically, coadministration of remdesivir with potent inducers of CYP450 3A4 may decrease the plasma concentration of remdesivir, which has been shown in vitro to be a substrate of the isoenzyme. However, the potential for this interaction appears low as remdesivir's metabolism is predominantly mediated by hydrolysis via esterases in vivo, which are not significantly affected by CYP450 3A4. When a single dose of remdesivir (100 mg) was administered to healthy volunteers on carbamazepine (300 mg twice daily), remdesivir's peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 13% and 8%, respectively. One of remdesivir's metabolites (GS-704277) had no change in its Cmax or AUC, while its other metabolite (GS-441524) had a reduction in AUC of 17%.
MANAGEMENT: Caution and clinical monitoring may be advisable if remdesivir is administered concurrently with potent inducers of CYP450 3A4 as they may reduce its concentrations and effects. While clinically significant interactions are not expected, some authorities recommend avoiding concomitant use of remdesivir with potent CYP450 3A4 inducers.
References (4)
- (2023) "Product Information. Veklury (remdesivir)." Gilead Sciences Canada Inc
- (2024) "Product Information. Veklury (remdesivir)." Gilead Sciences Pty Ltd, 6
- (2024) "Product Information. Veklury (remdesivir)." Gilead Sciences Ltd
- (2024) "Product Information. Veklury (remdesivir)." Gilead Sciences
Drug and food interactions
St. John's wort food
Applies to: st. john's wort
GENERALLY AVOID: An isolated case report suggests that foods containing large amounts of tyramine may precipitate a hypertensive crisis in patients treated with St. John's wort. The mechanism of interaction is unknown, as St. John's wort is not thought to possess monoamine oxidase (MAO) inhibiting activity at concentrations achieved in vivo. The case patient was a 41-year-old man who had been taking St. John's wort for seven days prior to presentation at the emergency room with confusion and disorientation. The patient recalled last eating aged cheese and having a glass of red wine approximately 10 hours prior to admission. No other cause of delirium or hypertension could be identified. In addition, alcohol may potentiate some of the pharmacologic effects of St. John's wort. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Until further information is available, patients treated with St. John's wort should consider avoiding consumption of protein foods in which aging or breakdown of protein is used to increase flavor. These foods include cheese (particularly strong, aged or processed cheeses), sour cream, wine (particularly red wine), champagne, beer, pickled herring, anchovies, caviar, shrimp paste, liver (particularly chicken liver), dry sausage, figs, raisins, bananas, avocados, chocolate, soy sauce, bean curd, yogurt, papaya products, meat tenderizers, fava beans, protein extracts, and dietary supplements. Caffeine may also precipitate hypertensive crisis so its intake should be minimized as well. Patients should also be advised to avoid or limit consumption of alcohol.
References (1)
- Patel S, Robinson R, Burk M (2002) "Hypertensive crisis associated with St. John's Wort." Am J Med, 112, p. 507-8
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.